- Home
- SGMO vs OXSQ Comparison
SGMO vs OXSQ Comparison
Compare SGMO & OXSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- OXSQ
- Stock Information
- Founded
- SGMO 1995
- OXSQ 2003
- Country
- SGMO United States
- OXSQ United States
- Employees
- SGMO N/A
- OXSQ N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- OXSQ Blank Checks
- Sector
- SGMO Health Care
- OXSQ Finance
- Exchange
- SGMO Nasdaq
- OXSQ Nasdaq
- Market Cap
- SGMO 180.5M
- OXSQ 185.5M
- IPO Year
- SGMO 2000
- OXSQ N/A
- Fundamental
- Price
- SGMO $2.51
- OXSQ $2.50
- Analyst Decision
- SGMO Buy
- OXSQ
- Analyst Count
- SGMO 3
- OXSQ 0
- Target Price
- SGMO $7.00
- OXSQ N/A
- AVG Volume (30 Days)
- SGMO 7.3M
- OXSQ 469.5K
- Earning Date
- SGMO 11-12-2024
- OXSQ 11-05-2024
- Dividend Yield
- SGMO N/A
- OXSQ 16.80%
- EPS Growth
- SGMO N/A
- OXSQ N/A
- EPS
- SGMO N/A
- OXSQ N/A
- Revenue
- SGMO $52,291,000.00
- OXSQ $44,787,853.00
- Revenue This Year
- SGMO N/A
- OXSQ N/A
- Revenue Next Year
- SGMO $11.46
- OXSQ N/A
- P/E Ratio
- SGMO N/A
- OXSQ N/A
- Revenue Growth
- SGMO N/A
- OXSQ N/A
- 52 Week Low
- SGMO $0.30
- OXSQ $2.44
- 52 Week High
- SGMO $3.18
- OXSQ $3.29
- Technical
- Relative Strength Index (RSI)
- SGMO 55.54
- OXSQ 28.37
- Support Level
- SGMO $2.24
- OXSQ $2.44
- Resistance Level
- SGMO $2.82
- OXSQ $2.66
- Average True Range (ATR)
- SGMO 0.28
- OXSQ 0.04
- MACD
- SGMO 0.02
- OXSQ -0.01
- Stochastic Oscillator
- SGMO 52.88
- OXSQ 24.40
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About OXSQ Oxford Square Capital Corp.
Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing, and Diversified Insurance.